Specifically, patients with lymphoma, colorectal cancer, and hepatocellular carcinoma demonstrated significantly higher frequencies of aPL than healthy controls, with IgM aCL and IgM anti-β2-GPI showing highest prevalence. The gene discussed is ACLY; the disease is colorectal cancer.